Bolt Biotherapeutics Statistics
Total Valuation
BOLT has a market cap or net worth of $9.24 million. The enterprise value is $4.70 million.
Important Dates
The next estimated earnings date is Monday, May 11, 2026, after market close.
| Earnings Date | May 11, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
BOLT has 1.92 million shares outstanding. The number of shares has decreased by -2.06% in one year.
| Current Share Class | 1.92M |
| Shares Outstanding | 1.92M |
| Shares Change (YoY) | -2.06% |
| Shares Change (QoQ) | -10.01% |
| Owned by Insiders (%) | 0.65% |
| Owned by Institutions (%) | 20.78% |
| Float | 1.77M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 1.20 |
| Forward PS | 1.51 |
| PB Ratio | 0.35 |
| P/TBV Ratio | 0.35 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 0.61 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.59, with a Debt / Equity ratio of 0.87.
| Current Ratio | 3.59 |
| Quick Ratio | 3.38 |
| Debt / Equity | 0.87 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -79.75% and return on invested capital (ROIC) is -32.83%.
| Return on Equity (ROE) | -79.75% |
| Return on Assets (ROA) | -27.68% |
| Return on Invested Capital (ROIC) | -32.83% |
| Return on Capital Employed (ROCE) | -71.68% |
| Weighted Average Cost of Capital (WACC) | 2.58% |
| Revenue Per Employee | $334,565 |
| Profits Per Employee | -$1.45M |
| Employee Count | 23 |
| Asset Turnover | 0.10 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -30.29% in the last 52 weeks. The beta is 0.86, so BOLT's price volatility has been lower than the market average.
| Beta (5Y) | 0.86 |
| 52-Week Price Change | -30.29% |
| 50-Day Moving Average | 4.66 |
| 200-Day Moving Average | 5.34 |
| Relative Strength Index (RSI) | 53.27 |
| Average Volume (20 Days) | 17,589 |
Short Selling Information
The latest short interest is 4,987, so 0.26% of the outstanding shares have been sold short.
| Short Interest | 4,987 |
| Short Previous Month | 908 |
| Short % of Shares Out | 0.26% |
| Short % of Float | 0.28% |
| Short Ratio (days to cover) | 0.04 |
Income Statement
In the last 12 months, BOLT had revenue of $7.70 million and -$33.38 million in losses. Loss per share was -$17.85.
| Revenue | 7.70M |
| Gross Profit | -20.84M |
| Operating Income | -34.63M |
| Pretax Income | -33.38M |
| Net Income | -33.38M |
| EBITDA | -33.34M |
| EBIT | -34.63M |
| Loss Per Share | -$17.85 |
Full Income StatementBalance Sheet
The company has $27.51 million in cash and $22.96 million in debt, with a net cash position of $4.55 million or $2.37 per share.
| Cash & Cash Equivalents | 27.51M |
| Total Debt | 22.96M |
| Net Cash | 4.55M |
| Net Cash Per Share | $2.37 |
| Equity (Book Value) | 26.51M |
| Book Value Per Share | 13.80 |
| Working Capital | 21.83M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$39.85 million and capital expenditures -$72,000, giving a free cash flow of -$39.92 million.
| Operating Cash Flow | -39.85M |
| Capital Expenditures | -72,000 |
| Depreciation & Amortization | 1.29M |
| Net Borrowing | n/a |
| Free Cash Flow | -39.92M |
| FCF Per Share | -$20.78 |
Full Cash Flow StatementMargins
| Gross Margin | -270.80% |
| Operating Margin | -450.07% |
| Pretax Margin | -433.74% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
BOLT does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 2.06% |
| Shareholder Yield | 2.06% |
| Earnings Yield | -361.11% |
| FCF Yield | -431.93% |
Analyst Forecast
The average price target for BOLT is $34.00, which is 606.86% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $34.00 |
| Price Target Difference | 606.86% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 3 |
| Revenue Growth Forecast (5Y) | 27.08% |
| EPS Growth Forecast (5Y) | 2.07% |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on June 9, 2025. It was a reverse split with a ratio of 1:20.
| Last Split Date | Jun 9, 2025 |
| Split Type | Reverse |
| Split Ratio | 1:20 |
Scores
BOLT has an Altman Z-Score of -12.53 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -12.53 |
| Piotroski F-Score | 3 |
